{
  "DOI": "10.1007/s10689-004-9552-0",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-004-9552-0",
  "alternative-id": [
    "5379552"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Robles-dï¿½az",
      "given": "Luis",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Goldfrank",
      "given": "Deborah J",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kauff",
      "given": "Noah D",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Robson",
      "given": "Mark",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Offit",
      "given": "Kenneth",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2004,
        10,
        30
      ]
    ],
    "date-time": "2004-10-30T01:06:34Z",
    "timestamp": 1099098394000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:45:53Z",
    "timestamp": 1559252753000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        12,
        25
      ]
    ],
    "date-time": "2023-12-25T02:27:07Z",
    "timestamp": 1703471227259
  },
  "is-referenced-by-count": 29,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3-4",
  "issued": {
    "date-parts": [
      [
        2004
      ]
    ]
  },
  "journal-issue": {
    "issue": "3-4",
    "published-print": {
      "date-parts": [
        [
          2004
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2004,
            1,
            1
          ]
        ],
        "date-time": "2004-01-01T00:00:00Z",
        "timestamp": 1072915200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-004-9552-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-004-9552-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-004-9552-0",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "259-264",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2004
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2004
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/canjclin.54.1.8",
      "author": "A Jemal",
      "doi-asserted-by": "crossref",
      "first-page": "8",
      "journal-title": "CA Cancer J Clin",
      "key": "CR1",
      "unstructured": "Jemal A, Tiwari RC, Murray T et al.Cancer statistics, 2004.CA Cancer J Clin2004;54:8?29.",
      "volume": "54",
      "year": "2004"
    },
    {
      "key": "CR2",
      "unstructured": "Ries LAG, Eisen MP, Kosary CL et al.(eds).SEER Cancer Statistics Review, 1973 ?1999.Bethesda, Maryland:National Can-cer Institute 2002.",
      "volume-title": "SEER Cancer Statistics Review, 1973 ?1999",
      "year": "2002"
    },
    {
      "DOI": "10.1016/0002-9378(89)90221-4",
      "author": "P Hartge",
      "doi-asserted-by": "crossref",
      "first-page": "10",
      "journal-title": "Am J Obstet Gynecol",
      "key": "CR3",
      "unstructured": "Hartge P, Schiffman MH, Hoover R et al.A case-control study of epithelial ovarian cancer.Am J Obstet Gynecol1989;161:10?6.",
      "volume": "161",
      "year": "1989"
    },
    {
      "author": "L McGowan",
      "first-page": "195",
      "journal-title": "Eur J Gynaecol Oncol",
      "key": "CR4",
      "unstructured": "McGowan L, Norris HJ, Hartge P et al.Risk factors in ovarian cancer.Eur J Gynaecol Oncol 1988;9:195?9.",
      "volume": "9",
      "year": "1988"
    },
    {
      "DOI": "10.1016/S0002-9378(98)70372-2",
      "author": "B Godard",
      "doi-asserted-by": "crossref",
      "first-page": "403",
      "journal-title": "Am J Obstet Gynecol",
      "key": "CR5",
      "unstructured": "Godard B, Foulkes WD, Provencher D et al.Risk factors for familial and sporadic ovarian cancer among French Canadians:a case-control study.Am J Obstet Gynecol 1998;179:403?10.",
      "volume": "179",
      "year": "1998"
    },
    {
      "DOI": "10.1006/gyno.2000.6065",
      "author": "GJ Brown",
      "doi-asserted-by": "crossref",
      "first-page": "346",
      "journal-title": "Gynecol Oncol",
      "key": "CR6",
      "unstructured": "Brown GJ, St John DJ, Macrae FA, Aittomaki K.Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.Gynecol Oncol2001;80:346?9.",
      "volume": "80",
      "year": "2001"
    },
    {
      "DOI": "10.1126/science.2270482",
      "author": "JM Hall",
      "doi-asserted-by": "crossref",
      "first-page": "1684",
      "journal-title": "Science",
      "key": "CR7",
      "unstructured": "Hall JM, Lee MK, Newman B et al.Linkage of early-onset familial breast cancer to chromosome 17q21.Science 1990;250:1684?9.",
      "volume": "250",
      "year": "1990"
    },
    {
      "DOI": "10.1016/0140-6736(91)90076-2",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "82",
      "journal-title": "Lancet",
      "key": "CR8",
      "unstructured": "Narod SA, Feunteun J, Lynch HT et al.Familial breast-ovarian cancer locus on chromosome 17q12 ?q23.Lancet 1991;338:82?3.",
      "volume": "338",
      "year": "1991"
    },
    {
      "DOI": "10.1126/science.7545954",
      "author": "Y Miki",
      "doi-asserted-by": "crossref",
      "first-page": "66",
      "journal-title": "Science",
      "key": "CR9",
      "unstructured": "Miki Y, Swensen J, Shattuck-Eidens D et al.A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66?71.",
      "volume": "266",
      "year": "1994"
    },
    {
      "DOI": "10.1038/ng1095-198",
      "author": "JP Struewing",
      "doi-asserted-by": "crossref",
      "first-page": "198",
      "journal-title": "Nat Genet",
      "key": "CR10",
      "unstructured": "Struewing JP, Abeliovich D, Peretz T et al.The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.Nat Genet 1995;11:198?200.",
      "volume": "11",
      "year": "1995"
    },
    {
      "DOI": "10.1038/378789a0",
      "author": "R Wooster",
      "doi-asserted-by": "crossref",
      "first-page": "789",
      "journal-title": "Nature",
      "key": "CR11",
      "unstructured": "Wooster R, Bignell G, Lancaster J et al.Identification of the breast cancer susceptibility gene BRCA2.Nature 1995;378:789?92.",
      "volume": "378",
      "year": "1995"
    },
    {
      "DOI": "10.1038/ng0596-126",
      "author": "S Neuhausen",
      "doi-asserted-by": "crossref",
      "first-page": "126",
      "journal-title": "Nat Genet",
      "key": "CR12",
      "unstructured": "Neuhausen S, Gilewski T, Norton L et al.Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.Nat Genet 1996;13:126?8.",
      "volume": "13",
      "year": "1996"
    },
    {
      "DOI": "10.1002/humu.1380080102",
      "author": "FJ Couch",
      "doi-asserted-by": "crossref",
      "first-page": "8",
      "journal-title": "Hum Mutat",
      "key": "CR13",
      "unstructured": "Couch FJ, Weber BL.Mutations and poymorphisms in the familial early-onset breast cancer (BRCA1 )gene.Breast cancer information core.Hum Mutat 1996;8:8?18.",
      "volume": "8",
      "year": "1996"
    },
    {
      "DOI": "10.1038/ng1096-185",
      "author": "BB Roa",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "journal-title": "Nat Genet",
      "key": "CR14",
      "unstructured": "Roa BB, Boyd AA, Volcik K, Richards CS.Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.Nat Genet 1996;14:185?7.",
      "volume": "14",
      "year": "1996"
    },
    {
      "DOI": "10.1086/302853",
      "author": "R Moslehi",
      "doi-asserted-by": "crossref",
      "first-page": "1259",
      "journal-title": "Am J Hum Genet",
      "key": "CR15",
      "unstructured": "Moslehi R, Chu W, Karlan B et al.BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.Am J Hum Genet 2000;66:1259?72.",
      "volume": "66",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJM200107263450401",
      "author": "B Modan",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "journal-title": "N Engl J Med",
      "key": "CR16",
      "unstructured": "Modan B, Hartge D, Hirsch-Yechezkel G et al.Parity, oral contraceptives and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.N Engl J Med 2001; 345:235?40.",
      "volume": "345",
      "year": "2001"
    },
    {
      "author": "ZQ Yuan",
      "first-page": "790",
      "journal-title": "J Med Genet",
      "key": "CR17",
      "unstructured": "Yuan ZQ, Wong N, Foulkes WD et al.A missense mutation in both h MSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening.J Med Genet1999;36:790?3.",
      "volume": "36",
      "year": "1999"
    },
    {
      "DOI": "10.1086/345075",
      "author": "WD Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "1395",
      "journal-title": "Am J Hum Genet",
      "key": "CR18",
      "unstructured": "Foulkes WD, Thiffault I, Gruber SB et al.The founder mutation MSH2 *1906g-\u003ec is an important cause of hereditary nonpolyp-osis colorectal cancer in the Ashkenazi Jewish population.Am J Hum Genet 2002;71:1395?412.",
      "volume": "71",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S1072-7515(02)01808-2",
      "author": "JG Guillem",
      "doi-asserted-by": "crossref",
      "first-page": "222",
      "journal-title": "J Am Coll Surg",
      "key": "CR19",
      "unstructured": "Guillem JG, Rapaport BS, Kirchhoff T et al.A636P is associated with early-onset colon cancer in Ashkenazi Jews.J Am Coll Surg 2003;196:222?5.",
      "volume": "196",
      "year": "2003"
    },
    {
      "author": "AS Whittemore",
      "first-page": "496",
      "journal-title": "Am J Hum Genet",
      "key": "CR20",
      "unstructured": "Whittemore AS, Gong G, Itnyre J.Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer:results from three US population-based case-control studies of ovarian cancer.Am J Hum Genet 1997;60:496?504.",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1002/cncr.11341",
      "author": "SC. Rubin",
      "doi-asserted-by": "crossref",
      "first-page": "2127",
      "journal-title": "Cancer",
      "key": "CR21",
      "unstructured": "Rubin SC.BRCA-related ovarian carcinoma.Cancer 2003;97:2127?9.",
      "volume": "97",
      "year": "2003"
    },
    {
      "DOI": "10.1086/302320",
      "author": "P Hartge",
      "doi-asserted-by": "crossref",
      "first-page": "963",
      "journal-title": "Am J Hum Genet",
      "key": "CR22",
      "unstructured": "Hartge P, Struewing JP, Wacholder S et al.The Prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 1999;64:963?70.",
      "volume": "64",
      "year": "1999"
    },
    {
      "DOI": "10.1136/jmg.39.8.611",
      "author": "N Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "611",
      "journal-title": "J Med Genet",
      "key": "CR23",
      "unstructured": "Kauff N, Perez-Segura P, Robson M et al.Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families.J Med Genet2002;39:611?4.",
      "volume": "39",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2002.20.6.1480",
      "author": "TS Frank",
      "doi-asserted-by": "crossref",
      "first-page": "1480",
      "journal-title": "J Clin Oncol",
      "key": "CR24",
      "unstructured": "Frank TS, Deffenbaugh AM, Reid JE et al.Clinical chracteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10, 000 individuals.J Clin Oncol 2002;20:1480?90.",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0140-6736(94)91578-4",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "692",
      "journal-title": "Lancet",
      "key": "CR25",
      "unstructured": "Ford D, Easton DF, Bishop DT et al.Risks of cancer in BRCA1-mutation carriers.Breast Cancer Linkage Consortium.Lancet 1994;343:692?5.",
      "volume": "343",
      "year": "1994"
    },
    {
      "key": "CR26",
      "unstructured": "Easton DF, Ford D, Bishop DT.Breast and ovarian cancer incidence in BRCA1-mutation carriers.Breast Cancer Linkage Consortium.Am J Hum Genet 1995;56:265 ?71."
    },
    {
      "DOI": "10.1002/(SICI)1098-2272(200002)18:2\u003c173::AID-GEPI6\u003e3.0.CO;2-R",
      "author": "AC Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "journal-title": "Genet Epidemiol",
      "key": "CR27",
      "unstructured": "Antoniou AC, Gayther SA, Stratton JF et al.Risk models for familial breast and ovarian cancer.Genet Epidemiol 2000;18:173?90",
      "volume": "18",
      "year": "2000"
    },
    {
      "DOI": "10.1086/301749",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "676",
      "journal-title": "Am J Hum Genet",
      "key": "CR28",
      "unstructured": "Ford D, Easton DF, Stratton M et al.Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families.Am J Hum Genet 1998;62:676?89.",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1093/jnci/94.16.1221",
      "author": "C. Begg",
      "doi-asserted-by": "crossref",
      "first-page": "1221",
      "journal-title": "JNCI",
      "key": "CR29",
      "unstructured": "Begg C.On the use of familial aggregation in population-based case probands for calculating penetrance.JNCI 2002;94:1221?6.",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1054/bjoc.2000.1407",
      "author": "[No authors listed ].",
      "doi-asserted-by": "crossref",
      "first-page": "1301",
      "journal-title": "Br J Cancer",
      "key": "CR30",
      "unstructured": "[No authors listed ].Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases.Anglian Breast Cancer Study Group.Br J Cancer 2000;83:1301?8.",
      "volume": "83",
      "year": "2000"
    },
    {
      "DOI": "10.1086/318787",
      "author": "HA Risch",
      "doi-asserted-by": "crossref",
      "first-page": "700",
      "journal-title": "Am J Hum Genet",
      "key": "CR31",
      "unstructured": "Risch HA, McLaughlin JR, Cole DE et al.Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.Am J Hum Genet 2001;68:700?10.",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "journal-title": "Am J Hum Genet",
      "key": "CR32",
      "unstructured": "Antoniou A, Pharoah PD, Narod S et al.Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:a combined analysis of 22 studies.Am J Hum Genet 2003;72:1117?30.",
      "volume": "72",
      "year": "2003"
    },
    {
      "author": "JM Satagopan",
      "first-page": "3776",
      "journal-title": "Clin Cancer Res",
      "key": "CR33",
      "unstructured": "Satagopan JM, Boyd J, Kauff N et al.Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Clin Cancer Res 2002;8:3776?81.",
      "volume": "8",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.1088759",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "journal-title": "Science",
      "key": "CR34",
      "unstructured": "King MC, Marks JH, Mandell JB et al.Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.Science 2003;302:643?6.",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1038/ng1295-428",
      "author": "SA Gayther",
      "doi-asserted-by": "crossref",
      "first-page": "428",
      "journal-title": "Nat Genet",
      "key": "CR35",
      "unstructured": "Gayther SA, Warren W, Mazoyer S et al.Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype ?phenotype correlation.Nat Genet 1995;11:428?33.",
      "volume": "11",
      "year": "1995"
    },
    {
      "author": "D Thompson",
      "first-page": "329",
      "journal-title": "Breast Cancer Linkage Consortium. Variation in BRCA1 cancer risks by mutation position.Cancer Epidemiol Biomarkers Prev",
      "key": "CR36",
      "unstructured": "Thompson D, Easton D.Breast Cancer Linkage Consortium. Variation in BRCA1 cancer risks by mutation position.Cancer Epidemiol Biomarkers Prev 2002;11:329?36.",
      "volume": "11",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/94.18.1365",
      "author": "MS Brose",
      "doi-asserted-by": "crossref",
      "first-page": "1365",
      "journal-title": "JNCI",
      "key": "CR37",
      "unstructured": "Brose MS, Rebbeck TR, Calzone KA et al.Cancer risk estimates for BRCA1 mutation carriers identi ed in a risk evaluation program.JNCI 2002;94:1365?72.",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1086/318181",
      "author": "D Thompson",
      "doi-asserted-by": "crossref",
      "first-page": "410",
      "journal-title": "Am J Hum Genet",
      "key": "CR38",
      "unstructured": "Thompson D, Easton D.Breast Cancer Linkage Consortium. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.Am J Hum Genet 2001;68:410?9.",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1038/nrc726",
      "author": "SA. Narod",
      "doi-asserted-by": "crossref",
      "first-page": "113",
      "journal-title": "Nat Rev Cancer",
      "key": "CR39",
      "unstructured": "Narod SA.Modifiers of risk of hereditary breast and ovarian cancer.Nat Rev Cancer 2002;3:113?23.",
      "volume": "3",
      "year": "2002"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200880",
      "author": "E Dagan",
      "doi-asserted-by": "crossref",
      "first-page": "724",
      "journal-title": "Eur J Hum Genet",
      "key": "CR40",
      "unstructured": "Dagan E, Friedman E, Paperna T et al.Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA 1/2 mutation carriers:association with breast/ovarian cancer phenotype.Eur J Hum Genet 2002;10:724?8.",
      "volume": "10",
      "year": "2002"
    },
    {
      "author": "DA Levine",
      "first-page": "908",
      "journal-title": "Cancer Res",
      "key": "CR41",
      "unstructured": "Levine DA, Boyd J.The androgen receptor and genetic suscep-tibility to ovarian cancer:results from a case series.Cancer Res 2001;61:908?11.",
      "volume": "61",
      "year": "2001"
    },
    {
      "author": "TR Rebbeck",
      "first-page": "5420",
      "journal-title": "Cancer Res",
      "key": "CR42",
      "unstructured": "Rebbeck TR, Wang Y, Kantoff PW et al.Modi cation of BRCA 1-and BRCA 2-associated breast cancer risk by AIB1 genotype and reproductive history.Cancer Res 2001;61:5420?4.",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1073/pnas.051624098",
      "author": "E Levy-Lahad",
      "doi-asserted-by": "crossref",
      "first-page": "3232",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "CR43",
      "unstructured": "Levy-Lahad E, Lahad A, Eisenberg S et al.A single nucleotide polymorphism in the RAD51 gene modi es cancer risk in BRCA 2 but not BRCA 1 carriers.Proc Natl Acad Sci USA 2001;98:3232?6.",
      "volume": "98",
      "year": "2001"
    },
    {
      "author": "JP Struewing",
      "first-page": "955",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "CR44",
      "unstructured": "Struewing JP et al.A single nucleotide polymorphism in the 5 Â¢UTR of RAD51 and risk of cancer among BRCA 1/2 mutation carriers.Cancer Epidemiol Biomarkers Prev 2001;10:955?960.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1038/ng0396-309",
      "author": "CM Phelan",
      "doi-asserted-by": "crossref",
      "first-page": "309",
      "journal-title": "Nat Genet",
      "key": "CR45",
      "unstructured": "Phelan CM, Rebbeck TR, Weber BL et al.Ovarian cancer risk in BRCA1 carriers is modi ed by the HRAS1 variable number of tandem repeat (VNTR)locus.Nat Genet 1996;12:309?11.",
      "volume": "12",
      "year": "1996"
    },
    {
      "DOI": "10.1002/ijc.2910640608",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "394",
      "journal-title": "Int J Cancer",
      "key": "CR46",
      "unstructured": "Narod SA, Goldgar D, Cannon-Albright L et al.Risk modifiers in carriers of BRCA1 mutations.Int J Cancer1995;64:394?8.",
      "volume": "64",
      "year": "1995"
    },
    {
      "DOI": "10.1001/jama.283.17.2260",
      "author": "J Boyd",
      "doi-asserted-by": "crossref",
      "first-page": "2260",
      "journal-title": "JAMA",
      "key": "CR47",
      "unstructured": "Boyd J, Sonoda Y, Federici MG et al.Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.JAMA 2000;283: 2260?5.",
      "volume": "283",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJM199611073351901",
      "author": "SC Rubin",
      "doi-asserted-by": "crossref",
      "first-page": "1413",
      "journal-title": "N Engl J Med",
      "key": "CR48",
      "unstructured": "Rubin SC, Benjamin I, Behbakht K et al.Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.N Engl J Med 1996;335:1413?6.",
      "volume": "335",
      "year": "1996"
    },
    {
      "DOI": "10.1200/JCO.2002.20.2.463",
      "author": "Y Ben David",
      "doi-asserted-by": "crossref",
      "first-page": "463",
      "journal-title": "J Clin Oncol",
      "key": "CR49",
      "unstructured": "Ben David Y, Chetrit A, Hirsch-Yechezkel G et al.Effect of BRCA mutations on the length of survival in epithelial ovarian tumors.J Clin Oncol 2002;20:463?6.",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1002/cncr.11310",
      "author": "I Cass",
      "doi-asserted-by": "crossref",
      "first-page": "2187",
      "journal-title": "Cancer",
      "key": "CR50",
      "unstructured": "Cass I, Baldwin, RL, Varkey T et al.Improved survival in women with BRCA-associated ovarian carcinoma.Cancer 2003; 97:2187?95.",
      "volume": "97",
      "year": "2003"
    },
    {
      "DOI": "10.1002/ijc.2910420217",
      "author": "G Kvale",
      "doi-asserted-by": "crossref",
      "first-page": "246",
      "journal-title": "Int J Cancer",
      "key": "CR51",
      "unstructured": "Kvale G, Heuch I, Nilssen S, Beral V.Reproductive factors and risk of ovarian cancer:a prospective study.Int J Cancer 1988;42:246?51.",
      "volume": "42",
      "year": "1988"
    },
    {
      "DOI": "10.1093/oxfordjournals.aje.a115076",
      "author": "ML Wu",
      "doi-asserted-by": "crossref",
      "first-page": "1216",
      "journal-title": "Am J Epidemiol",
      "key": "CR52",
      "unstructured": "Wu ML, Whittmore AS, Paffengarger RS et al.Personal and environmental characteristics related to epithelial ovarian cancer. I.Reproductive and menstrual events and oral contraceptive use. Am J Epidemiol 1988;128:1216?27.",
      "volume": "128",
      "year": "1988"
    },
    {
      "DOI": "10.1016/S0140-6736(94)90749-8",
      "author": "HO Adami",
      "doi-asserted-by": "crossref",
      "first-page": "1250",
      "journal-title": "Lancet",
      "key": "CR53",
      "unstructured": "Adami HO, Hsieh CC, Lambe M et al.Parity, age at rst childbirth, and risk of ovarian cancer.Lancet 1994;344:1250?4.",
      "volume": "344",
      "year": "1994"
    },
    {
      "DOI": "10.1016/0895-4356(90)90160-Q",
      "author": "ML Gwinn",
      "doi-asserted-by": "crossref",
      "first-page": "559",
      "journal-title": "J Clin Epidemiol",
      "key": "CR54",
      "unstructured": "Gwinn ML, Lee NC, Rhodes PH et al.Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 1990;43:559?68.",
      "volume": "43",
      "year": "1990"
    },
    {
      "author": "L Rosenberg",
      "first-page": "538",
      "journal-title": "Int J Epidemiol",
      "key": "CR55",
      "unstructured": "Rosenberg L, Shapiro S, Slone D et al.The WHO Collaborative Study of Neoplasia and Steroid contraceptives.Epithelial ovarian cancer and combined oral contraceptives.Int J Epidemiol 1987;18:538?45.",
      "volume": "18",
      "year": "1987"
    },
    {
      "author": "C La Vecchia",
      "first-page": "933",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "CR56",
      "unstructured": "La Vecchia C, Decarli A, Franceschi S et al.Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. Cancer Epidemiol Biomarkers Prev 1996;5:933?5.",
      "volume": "5",
      "year": "1996"
    },
    {
      "DOI": "10.1023/A:1024932427503",
      "author": "F Modugno",
      "doi-asserted-by": "crossref",
      "first-page": "439",
      "journal-title": "Cancer Causes \u0026Control",
      "key": "CR57",
      "unstructured": "Modugno F, Moslehi R, Ness RB et al.Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).Cancer Causes \u0026Control 2003;14:439?46.",
      "volume": "14",
      "year": "2003"
    },
    {
      "DOI": "10.1001/jama.1993.03510230051034",
      "author": "SE Hankinson",
      "doi-asserted-by": "crossref",
      "first-page": "2813",
      "journal-title": "JAMA",
      "key": "CR58",
      "unstructured": "Hankinson SE, Hunter DJ, Colditz GA et al.Tubal ligation, hysterectomy, and risk of ovarian cancer.JAMA 1993;270:2813?8.",
      "volume": "270",
      "year": "1993"
    },
    {
      "DOI": "10.1016/S0140-6736(00)04642-0",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "1467",
      "journal-title": "Lancet",
      "key": "CR59",
      "unstructured": "Narod SA, Sun P, Ghadirian P et al.Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations:a case-control study.Lancet 2001;357:1467?70.",
      "volume": "357",
      "year": "2001"
    },
    {
      "DOI": "10.1093/oxfordjournals.aje.a116427",
      "author": "AS Whittemore",
      "doi-asserted-by": "crossref",
      "first-page": "1184",
      "journal-title": "Am J Epidemiol",
      "key": "CR60",
      "unstructured": "Whittemore AS, Harris R, Itnyre J.Collaborative Ovarian Cancer Group.Characteristics relating to ovarian cancer risk:collaborative analysis of 12 US case-control studies.II.Invasive epithelial ovarian cancers in white women.Am J Epidemiol 1992;136:1184?203.",
      "volume": "136",
      "year": "1992"
    },
    {
      "DOI": "10.1002/ijc.2910490112",
      "author": "S Franceschi",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "journal-title": "Int J Cancer",
      "key": "CR61",
      "unstructured": "Franceschi S, Parazzinai F, Negri E et al.Pooled analysis of 3 European case-control studies of epithelial ovarian cancer.III. Oral contraceptive use.Int J Cancer 1991;49:61?5.",
      "volume": "49",
      "year": "1991"
    },
    {
      "DOI": "10.1056/NEJM199808133390702",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "424",
      "journal-title": "N Engl J Med",
      "key": "CR62",
      "unstructured": "Narod SA, Risch H, Moslehi R et al.Oral contraceptives and the risk of hereditary ovarian cancer.N Engl J Med 1998;339:424?8.",
      "volume": "339",
      "year": "1998"
    },
    {
      "DOI": "10.1056/NEJM200112063452312",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "1706",
      "journal-title": "N Engl J Med",
      "key": "CR63",
      "unstructured": "Narod SA, Sun P, Risch HA.Ovarian cancer, oral contraceptives, and BRCA mutations.N Engl J Med 2001;345:1706?7.",
      "volume": "345",
      "year": "2001"
    },
    {
      "author": "G Ursin",
      "first-page": "3678",
      "journal-title": "Cancer Res",
      "key": "CR64",
      "unstructured": "Ursin G, Henderson BE, Haile RW et al.Does oral contraceptive use increase the risk of breast cancer in women with BRCA 1/ BRCA 2 mutations more than in other women?Cancer Res 1997; 57:3678?81.",
      "volume": "57",
      "year": "1997"
    },
    {
      "DOI": "10.1001/jama.284.14.1791",
      "author": "DM Grabrick",
      "doi-asserted-by": "crossref",
      "first-page": "1791",
      "journal-title": "JAMA",
      "key": "CR65",
      "unstructured": "Grabrick DM, Hartmann LC, Cerhan JR et al.Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.JAMA 2000;284:1791?8.",
      "volume": "284",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJMoa020119",
      "author": "N Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "1609",
      "journal-title": "N Engl J Med",
      "key": "CR66",
      "unstructured": "Kauff N, Satagopan JM, Robson ME et al.Risk reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.N Engl J Med 2002;346:1609?15.",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJMoa012158",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1616",
      "journal-title": "N Engl J Med",
      "key": "CR67",
      "unstructured": "Rebbeck TR, Lynch HT, Neuhausen SL et al.Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616?22.",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/95.14.1072",
      "author": "JL Rutter",
      "doi-asserted-by": "crossref",
      "first-page": "1072",
      "journal-title": "JNCI",
      "key": "CR68",
      "unstructured": "Rutter JL, Wacholder S, Chetrit A et al.Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations:an Israeli population-based case-control study.JNCI 2003;95:1072?8.",
      "volume": "95",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/94.23.1773",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "1773",
      "journal-title": "JNCI",
      "key": "CR69",
      "unstructured": "Narod SA, Dube MP, Klijn J et al.Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. JNCI 2002;94(23):1773?9.",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0090-8258(03)00152-5",
      "author": "G Hirsh-Yechezkel",
      "doi-asserted-by": "crossref",
      "first-page": "494",
      "journal-title": "Gynecol Oncol",
      "key": "CR70",
      "unstructured": "Hirsh-Yechezkel G, Chetrit A, Lubin F et al.Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel.Gynecol Oncol2003;89:494?8.",
      "volume": "89",
      "year": "2003"
    },
    {
      "author": "[No authors listed ].",
      "key": "CR71",
      "unstructured": "[No authors listed ].GLOBOCAN 2000:Cancer incidence, mor-tality and prevalence worldwide.IARC CancerBase.Lyon, France, 2001.",
      "volume-title": "Cancer incidence, mor-tality and prevalence worldwide",
      "year": "2000"
    },
    {
      "DOI": "10.1002/(SICI)1098-2272(1998)15:1\u003c51::AID-GEPI4\u003e3.0.CO;2-7",
      "doi-asserted-by": "crossref",
      "key": "CR72",
      "unstructured": "Steinberg KK, Pernarelli JM, Marcus M et al.Increased risk for familial ovarian cancer among Jewish women:a population-based case-control study.Genet Epidemiol 15:51?9."
    },
    {
      "DOI": "10.1038/ng1294-392",
      "author": "J Simard",
      "doi-asserted-by": "crossref",
      "first-page": "392",
      "journal-title": "Nature Genet",
      "key": "CR73",
      "unstructured": "Simard J, Tonin P, Durocher F et al.Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.Nature Genet 1994;8:392?8.",
      "volume": "8",
      "year": "1994"
    }
  ],
  "reference-count": 73,
  "references-count": 73,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-004-9552-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Hereditary ovarian cancer in Ashkenazi Jews"
  ],
  "type": "journal-article",
  "volume": "3"
}